MedPath

A prospective study of the optimal depth of anesthesia for remimazolam anesthesia

Not Applicable
Conditions
ot specified
Registration Number
JPRN-UMIN000044418
Lead Sponsor
Tohoku University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Pregnant and lactating women (2) Patients with Child-Pugh classification C or higher (3) Patients with central nervous system diseases and psychiatric diseases (4) Patients who regularly use CNS-acting drugs (5) Heavy drinkers of alcohol and illegal drugs (6) Patients who cannot communicate in Japanese (7) Patients who had an adverse reaction to remimazolam and required a change in anesthetic (8) Patients who could not be awakened from anesthesia and extubated in the operating room immediately after the completion of surgery

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
EEG changes during remimazolam anesthesia
Secondary Outcome Measures
NameTimeMethod
The validity of a commercially available depth of anesthesia monitor
© Copyright 2025. All Rights Reserved by MedPath